1. Home
  2. ESTA vs HRMY Comparison

ESTA vs HRMY Comparison

Compare ESTA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Establishment Labs Holdings Inc.

ESTA

Establishment Labs Holdings Inc.

HOLD

Current Price

$68.12

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$36.19

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESTA
HRMY
Founded
2004
2017
Country
Costa Rica
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ESTA
HRMY
Price
$68.12
$36.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$78.86
$49.75
AVG Volume (30 Days)
416.3K
651.2K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.44
EPS
N/A
3.17
Revenue
$190,973,000.00
$825,944,000.00
Revenue This Year
$29.17
$23.29
Revenue Next Year
$25.05
$15.98
P/E Ratio
N/A
$11.43
Revenue Growth
24.76
21.13
52 Week Low
$26.56
$25.52
52 Week High
$78.24
$40.93

Technical Indicators

Market Signals
Indicator
ESTA
HRMY
Relative Strength Index (RSI) 47.29 44.31
Support Level $63.47 $34.68
Resistance Level $68.98 $39.40
Average True Range (ATR) 4.01 1.32
MACD -0.88 -0.33
Stochastic Oscillator 34.37 32.84

Price Performance

Historical Comparison
ESTA
HRMY

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: